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OBJECTIVE—Physical inactivity is a risk factor for type 2
diabetes and may be more detrimental in ﬁrst-degree relative
(FDR) subjects, unmasking underlying defects of metabolism.
Using a positive family history of type 2 diabetes as a marker of
increased genetic risk, the aim of this study was to investigate the
impact of physical inactivity on adipose tissue (AT) metabolism
in FDR subjects.
RESEARCH DESIGN AND METHODS—A total of 13 FDR and
20 control (CON) subjects participated in the study. All were
studied before and after 10 days of bed rest using the glucose
clamp technique combined with measurements of glucose up-
take, lipolysis, and lactate release from subcutaneous abdominal
(SCAAT) and femoral (SCFAT) adipose tissue by the microdialy-
sis technique. Additionally, mRNA expression of lipases was
determined in biopsies from SCAAT.
RESULTS—Before bed rest, the FDR subjects revealed signiﬁ-
cantly increased glucose uptake in SCAAT. Furthermore, mRNA
expression of lipases was signiﬁcantly decreased in the SCAAT
of FDR subjects. Bed rest signiﬁcantly decreased lipolysis and
tended to increase glucose uptake in the SCFAT of both CON and
FDR subjects. In response to bed rest, SCAAT glucose uptake
signiﬁcantly increased in CON subjects but not in FDR subjects.
CONCLUSIONS—FDR subjects exhibit an abnormal AT metab-
olism including increased glucose uptake prior to bed rest.
However, the differences between FDR and CON subjects in AT
metabolism were attenuated during bed rest due to relatively
more adverse changes in CON subjects compared with FDR
subjects. Physical inactivity per se is not more deleterious in FDR
subjects as compared with CON subjects with respect to de-
rangements in AT metabolism. Diabetes 59:2790–2798, 2010
T
ype 2 diabetes is the product of a complex
interplay between genetic susceptibility and en-
vironmental factors. The best known environ-
mental modiﬁable risk factors for type 2 diabetes
are obesity and a low level of habitual physical activity (1).
Even though there is substantial evidence that a change
toward a healthy lifestyle halts the progression of type 2
diabetes (2), certain groups, including ﬁrst-degree rela-
tives (FDRs) of patients with type 2 diabetes, are at
increased risk of developing the disease (3). Type 2
diabetes has a major hereditary component (4), and FDR
subjects show multiple abnormalities in intermediary me-
tabolism and pancreatic islet cell function, displaying
insulin resistance despite normal glucose tolerance (5).
The metabolic defects include insufﬁcient insulin secre-
tion (6), decreased peripheral glucose uptake (7), and the
impaired antilipolytic effect of insulin in subcutaneous
adipose tissue (AT) (8).
AT is an active compartment in the lipid and glucose
metabolism of humans, but the role of AT metabolism in
the development of type 2 diabetes is not clariﬁed. AT,
along with skeletal muscle, is a site of peripheral insulin
resistance in type 2 diabetes (9). The role of AT in the
pathophysiology of insulin resistance can partly be attrib-
uted to lipolytic activity resulting in the mobilization of
free fatty acids (FFAs), which are deleterious for glucose
utilization and insulin action (10). However, AT may play a
more direct role since it is a site of deranged glucose
metabolism. Although AT is of minor quantitative impor-
tance for whole-body glucose disposal, the tissue pro-
duces lactate (11), which functions as a gluconeogenic
precursor in the liver (12). Previous studies have demon-
strated increased plasma lactate (13) and lactate release
from adipocytes (14) in FDR subjects.
In this study, we investigated in vivo AT glucose uptake,
lipolysis, and lactate release, as well as subcutaneous
abdominal adipose tissue (SCAAT) mRNA expression of
lipases and GLUT-4 in FDR and control (CON) subjects
prior to and after 10 days of bed rest. We hypothesized that
FDR subjects would show abnormalities in baseline AT
metabolism and be more sensitive to the unhealthy effects
of physical inactivity.
RESEARCH DESIGN AND METHODS
The data presented in this article are part of a larger study on the inﬂuence of
physical inactivity in healthy and pre-diabetic subjects as initiated and funded
within the framework program of the European Union’s EXGENESIS
Consortium.
Thirty-three young healthy men participated in the study, which included
13 FDR of patients with type 2 diabetes and 20 CON subjects without any
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at term (FDR: 40  0.3 week; CON: 40  0.1 week). During inclusion, the
groups were matched with respect to age, BMI, and cardiorespiratory ﬁtness.
FDRs were recruited via their type 2 diabetic parent attending the outpatient
clinic at the Steno Diabetes Center, Gentofte, Denmark, and CON subjects
were recruited from the Danish National Birth Registry. CON and FDR
subjects had birth weights between the 50th and 75th percentile (CON:
3,827  49 g; FDR: 3,500  150 g, P  0.05). The purpose and potential risk of
the study were explained to all subjects before they gave their written
informed consent. The study was approved by the Ethical Committee of
Copenhagen and Frederiksberg, Denmark (protocol no. [01]-262546), and all
procedures used conformed to the Declaration of Helsinki II. All subjects had
normal fasting glucose measured before entering the study. Additional inclu-
sion criteria were male, aged 20–30 years, maximal oxygen uptake (VO2max)
35–55 ml  kg body mass
1  min
1 and BMI 18.5–24.9 kg per m
2.A n
International Physical Activity Questionnaire was answered before entering
the study. Subjects were Caucasian, and none took any medication. Subject
characteristics are summarized in Table 1.
Pre- and post–bed-rest testing. Fasting plasma glucose was determined in
capillary blood using an ABL 625 (Radiometer, Copenhagen, Denmark). Body
composition was determined by dual-energy X-ray absorptiometry full body
scanning (DPX-IQ, software version 4.7e; Lunar Radiation, Madison, WI), and
abdominal and femoral skinfold thickness were measured using a caliper
(Lafayette Instrument, Lafayette, IN). VO2max was measured using a bicycle
ergometer exercise protocol by means of an Oxycon Pro System (Jaeger,
Ho ¨chberg, Germany).
All subjects participated in one experimental day three weeks before ten
days of strict bed rest. On the tenth day of the bed-rest period, subjects
participated in a second and identical experimental day. Four days before the
ﬁrst experimental day, subjects were provided a standardized isocaloric diet
(i.e., 55 E% [percent of energy] of carbohydrates, 15 E% of protein, and 30 of
E% fat). Caloric ﬂuids, including alcohol, were prohibited. During these 4 days,
as well as during the bed-rest period, a combined accelerometer and heart rate
sensor (Actiheart; Cambridge Neurotechnology, Cambridge, U.K.) registered
movements and heart rate, and the energy expenditure was calculated. The
Actiheart device was placed on the subject’s upper left chest clipped on two
standard electrocardiogram electrodes. The participants wore the Actiheart
device continuously during the 4 days prior to the ﬁrst experiment and
throughout the entire bed- rest period. The set time resolution for measure-
ments was 30 s during the 4 days of “free living” and 1 min during the bed-rest
period. The data recorded from the Actiheart monitors were downloaded into
a database via the Actiheart reader/charger interface for assessment of
activity, heart rate, and calculated energy expenditure and analyzed using the
Actiheart commercial program provided with the device (Actiheart version 2.2
software). Data were edited with full traceability and without compromising
the integrity of the original recording. Subjects were instructed to continue
their daily living activities, including physical activity habits, during the 4 days
and in the 3 weeks prior to the bed-rest period and to refrain from vigorous
physical activity 24 h prior to the ﬁrst experimental day. During the bed-rest
period, subjects were in bed all day (a maximum of 60° upper body elevation)
under surveillance. A standardized isocaloric diet was provided during bed
rest with adjusted reduced amounts to ensure weight stability.
Experimental day protocol. The experimental day consisted of a 210-min
baseline period followed by a 180-min hyperinsulinemic euglycemic clamp.
Microdialysis catheters were inserted and dialysate was sampled during the
last 60 min of baseline and the last 60 min of the clamp period.
An arterial catheter (Becton Dickinson, U.K.) was inserted in the brachial
artery and blood was sampled at 180 and 210 min (basal) and at 360 and 390
min (clamp). A venous catheter (18G Venﬂon; Medex Medicine, U.K.) was
inserted in the medial antecubital vein for infusion of insulin and glucose.
Subcutaneous adipose tissue blood ﬂow (ATBF) was measured by the local
133Xe washout method (15).
Microdialysis. Prior to insertion of the microdialysis catheters (CMA60; CMA
Microdialysis AB, Solna, Sweden), the skin was anesthetized with 0.2 ml
lidocaine (Lidokain SAD, 5 mg/ml
1; Sygehus Apotekerne, Denmark). One
catheter was inserted in SCAAT 4 cm lateral to the umbilicus, and another
catheter was inserted in SCFAT of the leg adjacent to the vastus lateralis part
of the quadriceps muscle 30 cm above the patella. The catheters were
perfused with Ringer acetate containing 2 mmol/l glucose (Skanderborg
Apotek, Skanderborg, Denmark) at 1 l/min
1 using a high-precision syringe
pump (CMA100; CMA Microdialysis AB, Solna, Sweden). Dialysate was
immediately frozen and stored at 20°C.
The relative recovery over the membrane was determined using internal
reference calibration (16) and was used for the calculation of interstitial
metabolite concentrations. For internal reference calibration, 12 l D-1[
14C]-
glucose (PerkinElmer, Boston, MA) and 1 l 2-[
3H]-glycerol (PerkinElmer,
Boston, MA) was added to 10 ml of perfusate in order to achieve a speciﬁc
activity of 5 kBq/ml
1 for each isotope. Mean relative recovery for glucose and
glycerol were 45 and 55%. Relative recovery of lactate was assumed to equal
the relative recovery of glucose as found previously (17). Data were excluded
if relative recovery was less than 20%. The absolute rate of exchange of
glucose, glycerol, and lactate was calculated using Fick’s equation as de-
scribed previously (17,18).
Biochemical analysis. Blood samples for the analysis of glucose, glycerol,
lactate, FFA, and triglyceride were distributed in iced tubes containing 1.5 mg
ethylene-diamine-tetraacetic acid per ml blood. For the analysis of insulin, the
tubes contained 500 KIE Trasylol and 1.5 mg EDTA per ml blood. The tubes
were centrifuged (Hettich Labinstrument ApS, Hvidovre, Denmark) and
stored at 80°C. Plasma and microdialysate glucose, glycerol, and lactate
were determined by a CMA600 microdialysis analyzer (CMA Microdialysis AB,
Solna, Sweden). Plasma FFA was determined using a nonesteriﬁed fatty acids
C kit (Wako Chemicals, Neuss, Germany). Plasma insulin analysis was
determined by enzyme-linked immunosorbent assay (ELISA) technique
(DAKO ELISA, U.K.) and plasma triglyceride with Triglyceride GPO-PAP
(Roche Diagnostic, Mannheim, Germany).
Adipose tissue blood ﬂow. ATBF was measured by the local
133Xe washout
technique (15). Brieﬂy, 0.5–1 MBq gaseous
133Xe (Amersham Health, Amer-
sham, U.K.) was injected into the SCAAT and SCFAT contra lateral to the
regions in which microdialysis was performed. Washout of
133Xe was regis-
TABLE 1
Subject characteristics
Before bed rest After bed rest
CON FDR
aP CON FDR
bP
cP
Age (years) 25  0.2 26.1  1n s — — n mn m
VO2max (ml O2/kg/min) 43.5  1.5 39.1  1.9 ns 42.8  1.1 37.5  2.0 ns ns
VO2max (ml/min) 3,659  125 3,405  162 P  0.05 3,527  101 3,190  160 ns ns
Fasting arterial glucose (mmol/l) 5.3  0.1 5.5  0.1 ns 5.1  0.1 5.2  0.1 P  0.05 P  0.05
Weight (kg) 82.5  2.3 84.0  3.3 ns 82.2  2.3 83.6  3.2 ns ns
Height (m) 1.85  0.01 1.84  0.02 ns — — nm nm
BMI (kg/m
2) 24.1  0.5 24.9  0.9 ns 23.9  0.5 24.8  0.9 ns ns
Total fat mass (kg) 14.3  1.6 21.6  2.5 P  0.05 14.7  1.8 21.5  2.7 ns ns
Total lean mass (kg) 63.8  1.1 58.6  1.5 P  0.05 63.6  1.1 58.4  1.5 ns ns
Whole body fat percentage (%) 17.4  1.7 25.0  2.3 P  0.05 17.1  1.6 24.9  2.5 ns ns
Trunk fat mass/total fat mass 0.48  0.1 0.58  0.001 P  0.05 0.50  0.01 0.58  0.01 ns ns
Leg fat mass/total fat mass 0.37  0.1 0.29  0.01 P  0.05 0.37  0.01 0.29  0.01 ns ns
Waist/hip ratio 0.85  0.01 0.88  0.02 ns 0.86  0.01 0.87  0.02 ns ns
Abdominal skinfold (mm) 21  1.8 25  3.0 ns 21  1.6 23  2.0 ns ns
Femoral skinfold (mm) 16  1.5 16  2.0 ns 15  1.4 16  2.0 ns ns
Data are mean  SE.
aP, signiﬁcant difference between the groups before bed rest (P  0.05).
bP, signiﬁcant difference before vs. after bed
rest within CON, P  0.05.
cP, signiﬁcant difference before vs. after bed rest within FDR, P  0.05. ns, not signiﬁcant; nm, not measured.
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was calculated as described previously (19).
Whole-body glucose uptake. Whole-body glucose disposal was determined
using the hyperinsulinemic (40 mU  min
1  m
2(1)) (Actrapid; Novo Nordisk,
Copenhagen, Denmark) euglycemic clamp technique as described previously
(20). Whole-body insulin–mediated glucose uptake rates were averaged for 10
min and calculated as the mean of steady-state glucose infusion rates from t 
360 to t  390 (M value).
Adipose tissue biopsy. SCAAT biopsies were collected in the basal state and
at the end of a 180-min hyperinsulinemic (80 mU  min
1  m
2(1)) euglycemic
clamp before bed rest and on the ninth day of the bed-rest intervention using
the Bergstrom biopsy needle technique with suction under local anesthesia
(1% lidocaine). Biopsies were snap-frozen in liquid nitrogen and stored at
80°C.
Determination of mRNA levels. Total RNA was isolated using Trizol
reagent (Gibco BRL; Life Technologies, Roskilde, Denmark), and cDNA was
made with random hexamer primers using the GeneAmp PCR kit (Applied
Biosystems, CA). Glyceraldehyde-3-phosphate dehydrogenase (GADPH) was
chosen as housekeeping gene for hormone-sensitive lipase (HSL), lipoprotein
lipase (LPL), and adipose triglyceride lipase (ATGL), and -actin as house-
keeping gene for GLUT4. Quantiﬁcation was performed with a SYBR Green
real-time PCR assay using an iCycler PCR machine (Bio-Rad Laboratories,
Hercules, CA) as described previously (21).
Statistical analysis. The computer program SAS for Windows version 9.1
(SAS Institute, Cary, NC) was used for statistical analysis. Data were analyzed
using a linear mixed model. The model estimates differences between mean
values. Repeated measures data, as in the present study, requires special
attention to the covariance structure due to the sequential nature of the data
on each individual. The covariance structure refers to variances at individual
times and to correlation between measures at different times on the same
subject. In the mixed model, the variation between subjects is speciﬁed by the
RANDOM statement, and covariation within subjects is speciﬁed by the
REPEATED statement. In the present study, we assumed compound symme-
try in the model, i.e., that all measurements on the same subject were equally
correlated and had the same variance. The implication is that the only aspect
of the covariance between repeated measures is due to the subject contribu-
tion irrespective of proximity of time. Compound symmetric structure was
ﬁtted with the RANDOM statement. The ﬁxed effects parameters: group,
experimental day and time was included in the MODEL statement of the
analysis.
The ﬁgures presented (Figs. 1–3) are absolute means, while the differences
and CIs described in the results section are from the linear mixed model. If
data were not normally distributed or homogeneous as assessed by residual
plots of each dependent variable, log transformation data were used and
signiﬁcant effects described as relative (%) differences. We evaluated the effect
of groups (CON and FDR), the effect of bed rest (before vs. after), and time
(baseline or insulin-stimulated) and tested an eventual differential effect of
bed rest between FDR and CON subjects by including interaction between
groups and bed rest and the marginal effects in the model. Threshold for
signiﬁcance was P  0.05. The Bonferroni corrected P value that is equivalent
to an uncorrected P value of 0.05 in the present study is P  0.0028, although
this is likely overly conservative. However in the interpretation of the results,
the risks of type I errors are acknowledged. Data are presented as absolute
means  SE (ﬁgures) or differences and CI.
RESULTS
FDR subjects were characterized by increased body fat
percentage and abdominal adiposity compared with CON
subjects, but similar BMI and waist-to-hip ratio (Table 1).
In response to bed rest, no changes in anthropometrics
were observed. Total, resting, and activity-related energy
expenditure and the physical activity score (Actiheart
recordings) did not differ between groups during daily
living but decreased signiﬁcantly in both groups during
bed rest with no difference between groups (Table 2).
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FIG. 1. SCAAT and SCFAT glucose uptake in the basal state (no pattern) and the insulin-stimulated state (patterned) before (gray) and after
(black) bed rest (BR) in CON and FDR of type 2 diabetic subjects. *Basal (P  0.005) and insulin-stimulated state (P  0.02) before bed rest,
CON vs. FDR. **Basal (P  0.01) and insulin-stimulated state (P  0.02) before vs. after bed rest in CON.
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lower in FDR subjects compared with CON subjects
before bed rest (P  0.035) but when expressing VO2max
per kg body weight, there was no difference between
groups. VO2max did not change signiﬁcantly in response to
bed rest in FDR subjects or CON subjects (Table 1).
Subcutaneous adipose tissue glucose uptake
Abdominal. The interstitial glucose concentration in
SCAAT was signiﬁcantly lower than plasma water glucose
indicating that glucose is taken up in SCAAT in both
groups (Table 3). Before bed rest, basal and insulin-
stimulated SCAAT glucose uptake was higher in FDR
subjects compared with CON subjects (difference basal:
1.21 nmol  100 g
1  min
1, 95% CI 0.39–2.02, P  0.005;
difference insulin-stimulated: 0.94 nmol  100 g
1  min
1,
95% CI 0.17–1.72, P  0.02) with no differences between
groups after bed rest (Fig. 1). The difference disappeared
as glucose uptake increased only in CON in response to
bed rest (difference basal: 1.1 nmol  100 g
1  min
1, 95%
CI 0.3–1.9, P  0.01; difference insulin-stimulated: 0.7 nmol
 100 g
1  min
1, 95% CI 0.1–1.4, P  0.02). Test for
interaction between groups and bed rest was signiﬁcant in
the basal state (P  0.02) and during insulin stimulation
(P  0.047). Insulin did not stimulate SCAAT glucose
uptake in either of the groups (Fig. 1).
Femoral. Also in SCFAT, the interstitial glucose concen-
tration was signiﬁcantly lower than the arterial plasma
water concentration indicating that glucose is taken up in
SCFAT in both groups (Table 3). SCFAT glucose uptake
did not differ between groups before or after bed rest.
There was a nonsigniﬁcant tendency to increased SCFAT
glucose uptake in both groups after bed rest (P  0.06).
Insulin did not stimulate SCFAT glucose uptake in any of
the groups (Fig. 1).
Subcutaneous adipose tissue lipolysis
Abdominal. The concentration of glycerol was signiﬁ-
cantly higher in the interstitial ﬂuid than in the arterial
plasma water indicating glycerol release from and thus
lipolysis in SCAAT in both groups (Table 3). SCAAT
lipolysis did not differ between groups before or after bed
rest and did not inﬂuence SCAAT lipolysis in either of the
groups (Fig. 2). Insulin inhibited SCAAT lipolysis in both
groups before (FDR: P  0.006, CON: P  0.01) and after
bed rest (FDR: P  0.004, CON: P  0.0009).
Femoral. Also in SCFAT, the concentration of glycerol
was signiﬁcantly higher in the interstitial ﬂuid than in the
arterial plasma water indicating lipolysis in the tissue in
both groups (Table 3). Lipolysis did not differ between
groups before or after bed rest (Fig. 2). However after bed
rest, basal lipolysis was decreased in both FDR (difference
before vs. after bed rest: 43%, 95% CI 29–64, P  0.0006)
and CON (difference before vs. after bed rest: 62%, 95% CI
42–91, P  0.02). In FDR, insulin-inhibited lipolysis was
also decreased after bed rest (difference before vs. after
bed rest: 50%, 95% CI 31–81, P  0.009). Insulin inhibited
SCFAT lipolysis in both groups before (FDR: P  0.0004,
CON: P  0.0001) and after bed rest (FDR: P  0.02, CON:
P  0.02).
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FIG. 2. SCAAT and SCFAT lipolysis in the basal state (no pattern) and the insulin-stimulated state (patterned) before (gray) and after (black)
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Abdominal. Lactate concentrations were signiﬁcantly
higher in the interstitial space than in the arterial plasma
water indicating that lactate is released from SCAAT in
both groups (Table 3). SCAAT lactate release did not differ
between the groups before or after bed rest and did not
change in response to bed rest or insulin stimulation in
either of the groups (Fig. 3).
Femoral. Also in SCFAT, lactate concentrations were
signiﬁcantly higher in the interstitial space than in the
arterial plasma water indicating lactate release in both
groups (Table 3). Before bed rest, there was a nonsigniﬁ-
cant tendency to lower SCFAT lactate release in FDR
compared with CON (P  0.06), while lactate release was
similar after bed rest (Fig. 3). Bed rest and insulin did not
inﬂuence SCFAT lactate release in either of the groups.
Whole-body insulin sensitivity. Before bed rest, whole-
body insulin sensitivity (M value) was lower (P  0.05) in
FDR compared with CON (4.3  0.5 vs. 6.8  0.5 mg 
min
1 kg
1), and bed rest decreased the M value in both
FDR (P  0.007) and CON (P  0.0001) although less in
FDR compared with CON (28  1% vs. 37  4%, P  0.05).
After bed rest, the M value was still lower in FDR
compared with CON (3.1  0.3 vs. 4.3  0.3 mg  min
1
kg
1, P  0.05).
Subcutaneous adipose tissue blood ﬂow. SCAAT blood
ﬂow did not differ between groups before or after bed rest
and did not change in response to bed rest or insulin
stimulation in either of the groups (data not shown).
Before bed rest, SCFAT blood ﬂow was lower in FDR
compared with CON during insulin stimulation (1.03 ml 
100 g
1  min
1, 95% CI 0.39–1.69, P  0.003). SCFAT
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(black) bed rest (BR) in CON and FDR of type 2 diabetic subjects.
TABLE 2
Energy expenditure and physical activity level before and during bed rest
Daily living During bed rest
CON FDR
aP CON FDR
bP
cP
Resting energy expenditure (REE) (kJ/day/kg) 99  1.0 96  2.7 ns 101  1.4 97  2.4 ns ns
Activity energy expenditure (AEE) (kJ/day/kg) 83  7 102  8n s 2 6  42 7  3 P  0.0001 P  0.0001
Total energy expenditure (TEE) (kJ/day/kg) 207  8 218  12 ns 146  5 138  4 P  0.0001 P  0.0001
Daily physical activity level (PAL) (TEE/REE) 2.1  0.1 2.3  0.1 ns 1.5  0.05 1.4  0.03 P  0.0001 P  0.0001
Sitting (hours/day) 7.2  0.6 6.5  0.9 ns — — — —
Data are mean  SE.
aP, signiﬁcant difference between the groups before bed rest.
bP, signiﬁcant difference before vs. after bed rest within
CON.
cP, signiﬁcant difference before vs. after bed rest within FDR. ns, nonsigniﬁcant. REE, AEE, TEE, and PAL based on Actiheart
recordings during 4 days of daily living 3 weeks before bed rest. Hours sitting per day based on International Physical Activity Questionnaire.
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insulin stimulation in any of the groups (data not shown).
Arterial plasma glucose, glycerol, lactate, FFA, tri-
glyceride, and insulin. Fasting plasma glucose was higher
(P  0.002) in FDR compared with CON before and after
bed rest and decreased in both groups after bed rest (P 
0.0001) (Table 4). Fasting plasma glycerol did not differ
between CON and FDR before or after bed rest and did not
change in response to bed rest in any of the groups but
decreased (P  0.0001) during insulin stimulation in both
groups. Plasma lactate was similar between the groups
before bed rest but was lower in FDR compared with CON
after bed rest during insulin stimulation (P  0.03). Plasma
lactate increased during insulin stimulation in CON before
bed rest (P  0.007) and decreased in FDR (P  0.03) after
bed rest. Before bed rest, fasting (P  0.045) as well as
insulin-stimulated (P  0.008) plasma FFA were higher in
FDR, but after bed rest only insulin-stimulated concentra-
tions remained different between groups (P  0.03). Bed
rest did not inﬂuence plasma FFA in any of the groups
while plasma FFA decreased during insulin stimulation in
both groups (P  0.01). Basal plasma triglyceride concen-
trations were higher in FDR before (P  0.04) and after
bed rest (P  0.03) and increased in response to bed rest
in FDR (P  0.03) but not in CON (P  0.7). Testing for
interaction between groups and bed rest was nonsigniﬁ-
cant (P  0.32) and thus does not support a differential
effect of bed rest between the groups but a main effect.
Thus, plasma triglyceride concentrations increased in both
groups in response to bed rest (P  0.04). Insulin inhibited
plasma triglyceride concentrations in both groups (P 
0.02). Fasting plasma insulin was elevated in FDR com-
pared with CON before (P  0.02) and after bed rest (P 
0.04) and did not change in response to bed rest in any of
the groups.
ATGL, HSL, LPL, and GLUT4 mRNA expression in
SCAAT. Basal SCAAT ATGL expression was lower (P 
0.05) in FDR compared with CON before bed rest and did
not change in response to bed rest in any of the groups
(Table 5). In FDR, ATGL expression increased in response
to insulin stimulation before and after bed rest (P  0.04).
Basal HSL expression was lower (P  0.0001) in FDR
compared with CON before and after bed rest and did not
change in response to bed rest in any of the groups (Table
5). In FDR, HSL expression increased in response to
insulin stimulation before (P  0.01) and after bed rest
(P  0.006). Basal LPL expression was lower (P  0.0001)
in FDR compared with CON before and after bed rest. In
CON, but not in FDR, basal LPL expression increased (P 
0.02) markedly in response to bed rest, and the interaction
between group and bed rest (P  0.017) supported this.
During insulin stimulation, LPL expression increased in
FDR before (P  0.03) and after bed rest (P  0.006).
GLUT-4 expression did not differ between CON and FDR
and did not change in response to bed rest in either of the
groups. In both groups, insulin stimulation increased
TABLE 3
Basal subcutaneous adipose tissue interstitial and plasma water concentrations of metabolites
CON FDR
Before BR After BR Before BR After BR
Interstitial glucose abdominal (M) 4.4  0.2 (n  19)* 3.6  0.4 (n  18)* 4.0  0.5 (n  11)* 4.5  0.3 (n  13)*
Interstitial glucose femoral (M) 4.7  0.2 (n  19)* 4.0  0.2 (n  19)* 5.7  0.4 (n  11)* 4.3  0.3 (n  11)*
Arterial plasma water glucose (M) 5.3  0.1 (n  20) 5.1  0.1 (n  20) 5.9  0.1 (n  13) 5.6  0.1 (n  13)
Interstitial glycerol abdominal (M) 235  29 (n  20) 172  13 (n  20)* 228  40 (n  13)* 241  39 (n  12)*
Interstitial glycerol femoral (M) 309  38 (n  20) 232  34 (n  19)* 355  49 (n  11)* 205  29 (n  12)*
Arterial plasma water glycerol (M) 36  3( n  20) 33  2( n  20) 42  4( n  13) 36  3( n  13)
Interstitial lactate abdominal (M) 2.7  0.2 (n  19)* 3.0  0.3 (n  18)* 3.1  0.5 (n  10)* 3.0  0.3 (n  13)*
Interstitial lactate femoral (M) 2.8  0.3 (n  19)* 3.1  0.3 (n  19)* 2.8  0.2 (n  10)* 2.6  0.3 (n  12)*
Arterial plasma water lactate (M) 0.8  0.06 (n  20) 0.8  0.05 (n  20) 0.8  0.08 (n  13) 0.8  0.05 (n  13)
Data are mean  SE. *Signiﬁcant difference interstitial vs. arterial plasma water concentration, P  0.05. BR, bed rest.
TABLE 4
Plasma glucose, glycerol, lactate, FFA, triglyceride, and insulin
CON FDR
Before bed rest After bed rest Before bed rest After bed rest
n 20 20 13 13
P glucose (mM) Basal 5.1  0.06*†‡ 4.8  0.05*† 5.4  0.1*† 5.2  0.1*†
P glucose (mM) Insulin stimulated 4.9  0.07* 4.8  0.07† 5.3  0.1*† 55.1  0.09*
P glycerol (M)** Basal 34.6  2.7‡ 31.2  2.1‡ 38.5  3.7‡ 34.2  2.9‡
P glycerol (M)** Insulin stimulated 14.5  0.9 13.9  0.9 14.7  1.2 13.0  1.0
P lactate (mM) Basal 0.7  0.05‡ 0.7  0.05 0.7  0.07 0.8  0.05‡
P lactate (mM) Insulin stimulated 0.9  0.05 0.8  0.04* 0.7  0.06 0.6  0.03*
P FFA (M) Basal 264  30*‡ 282  30‡ 369  46*‡ 307  36‡
P FFA (M) Insulin stimulated 13  2* 11  22 6  5* 20  3
P triglyceride (mM) Basal 0.9  0.1*‡ 1.0  0.1*‡ 1.1  0.1*†‡ 1.3  0.1*†‡
P triglyceride (mM) Insulin stimulated 0.5  0.05 0.6  0.1‡ 0.7  0.1 1.1  0.1‡
P insulin (pM) Basal 35  3* 35  3* 50  8* 47  5*
P insulin (pM) Insulin stimulated 294  10 272  13 287  26 308  22
Data are presented as mean  SE. *Signiﬁcant difference CON vs. FDR, P  0.05. †Signiﬁcant difference before vs. after bed rest within the
group; P  0.05. †Signiﬁcant difference basal vs. insulin-stimulated state within the group on the speciﬁed day, P  0.05. **Data were log
transformed before statistical test.
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P  0.02), but not before bed rest.
DISCUSSION
The major ﬁndings were that individuals with a family
history of type 2 diabetes (FDR) have a signiﬁcantly higher
glucose uptake in SCAAT compared with individuals not
predisposed (CON), and physical inactivity in individuals
not predisposed to type 2 diabetes increases SCAAT
glucose uptake to the same level as in predisposed indi-
viduals (Fig. 1). These differences were not found in
SCFAT. However, in SCFAT, but not in SCAAT, lipolysis
decreased in response to physical inactivity in both pre-
disposed individuals and those individuals not predis-
posed (Fig. 2). SCAAT mRNA expression of ATGL, HSL,
and LPL was consistently lower in FDR compared with
CON (Table 5) despite similar SCAAT lipolysis in the two
groups.
At the whole-body level, FDR subjects in the present
and several other studies (5,22) are clearly insulin resis-
tant. Whole-body insulin sensitivity, as determined by the
hyperinsulinemic-euglycemic clamp technique, is primar-
ily a measure of insulin-stimulated glucose uptake in
skeletal muscle, and we previously found insulin resis-
tance in skeletal muscle of FDR subjects as evidenced by
decreased insulin-stimulated forearm blood ﬂow and glu-
cose clearance (23). In another study, we found increased
glucose production in FDR subjects indicating hepatic
insulin resistance in these individuals (24). In a recent
study (25) as well as in the present study, we found higher
glucose uptake in SCAAT in FDR indicating redirection of
glucose uptake to AT promoted by a combination of
muscle insulin resistance and an increased rate of hepatic
glucose production as shown previously (24). Mice with
muscle-speciﬁc inactivation of the insulin receptor gene
(MIRKO) and, as a consequence, insulin resistance in
skeletal muscle, likewise show increased glucose uptake
in AT (26). Furthermore, MIRKO mice exhibit increased
fat mass, serum triglyceride, and FFA levels in face of
normoglycemia and normal body weight as also seen in
the FDR subjects of the present study. Thus, in the
pre-diabetic state, insulin resistance conﬁned to skeletal
muscle can induce dyslipidemia, increased AT glucose
uptake, and increased fat mass. We speculate that insulin
resistance will develop also in AT during the further
pathophysiological development toward type 2 diabetes,
possibly in response to a further increase in fat mass.
Interestingly, the shunting of glucose seems to be site-
speciﬁc as glucose uptake was increased in SCAAT but not
in SCFAT, which might explain the preferential localiza-
tion of fat in abdominal depots of the FDR subjects.
Glucose may be used for reesteriﬁcation of FFA via
glycerol-3-phosphate or oxidized, stored as triglyceride or
degraded to lactate. Lactate release in SCAAT was not
different between groups indicating that the extra glucose
taken up in SCAAT of FDR subjects takes other metabolic
pathways. A likely pathway is conversion to glycerol-3-
phosphate, which is a key substrate for lipid storage in
adipocytes. Also the tendency to decreased lactate release
in SCFAT of FDR combined with normal SCFAT glucose
uptake is leaving extra glucose for lipid storage.
Our study revealed that lipolysis in subcutaneous AT
was similar in predisposed individuals and those individ-
uals not predisposed. Despite normal lipolysis in FDR
subjects, we found increased plasma FFA concentrations,
which probably reﬂect an increased amount of AT in FDR
subjects. The reduced expression of ATGL and HSL found
in FDR subjects could contribute to the relatively high
abdominal fat mass. The low expression of LPL in FDR
could potentially increase plasma triglyceride, which we
did ﬁnd in the FDR subjects underpinning a metabolic
abnormal condition. AT lipolysis is very sensitive to the
action of insulin (27), and failure to adequately turn off
lipolysis could induce skeletal muscle and liver insulin
resistance through excessive availability of FFA (28). The
coexistence of normal SCAAT lipolysis and low mRNA
expression of lipases in FDR subjects could be explained
by the increased fasting plasma insulin levels in FDR
subjects and indicates a state of insulin resistance seen as
the failure to turn off lipolysis in AT of FDR subjects. The
low mRNA expression of AT lipases suggests that a
primary defect in the development of insulin resistance
relates to an impaired ability to regulate the activity of AT
lipases, which is important for the balance of triglyceride
storage and the mobilization of FFA.
CON subjects responded to bed rest by increasing
SCAAT glucose uptake to the same level as seen in FDR
subjects prior to bed rest. Bed rest induced whole-body
insulin resistance in both FDR and CON subjects, although
the decrease in insulin sensitivity was relatively less in
FDR subjects (29). When skeletal muscle reduces its
utilization of glucose as a consequence of physical inac-
TABLE 5
ATGL, HSL, LPL mRNA expression relative to GADPH, and GLUT-4 mRNA expression relative to -actin in SCAAT
CON FDR
Before BR rest (basal
n  16; insulin
stimulation n  14)
After BR (basal
n  16; insulin
stimulation n  16)
Before BR (basal
n  10; insulin
stimulation n  11)
After BR rest (basal
n  10; insulin
stimulation n  11)
ATGL** Basal 0.10  0.02* 0.10  0.01 0.04  0.02*‡ 0.06  0.04
ATGL** Insulin stimulation 0.12  0.03 0.11  0.02 0.08  0.02 0.07  0.01
HSL** Basal 0.10  0.02* 0.15  0.04* 0.02  0.01*‡ 0.01  0.01*‡
HSL** Insulin stimulation 0.08  0.01 0.09  0.02 0.09  0.03 0.06  0.02
LPL** Basal 1.2  0.2*† 2.3  0.4*† 0.4  0.1*‡ 0.3  0.2*‡
LPL** Insulin stimulation 1.8  0.4 1.7  0.2 1.0  0.2 1.1  0.3
GLUT 4** Basal 0.9  0.3 0.6  0.1‡ 1.0  0.3 1.0  0.3‡
GLUT 4** Insulin stimulation 0.8  0.2 1.2  0.2 0.6  0.2 2.3  0.8
Data are mean  SE. *Signiﬁcant difference CON vs. FDR, P  0.05. †Signiﬁcant difference before vs. after BR within the group; P  0.05.
‡Signiﬁcant difference basal vs. insulin-stimulated state within the group on the speciﬁed day, P  0.05. **Data were log transformed before
statistical test.
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resistant FDR subjects before BR. Also, SCAAT LPL
mRNA expression was upregulated after bed rest in CON
but not in FDR subjects. Increased FFA and glucose
uptake in SCAAT would tend to increase fat mass after bed
rest, which we did not ﬁnd. This may relate to the short
time frame and the fact that we aimed at a constant body
weight during the bed-rest period. However, a high AT
substrate uptake caused by a low level of physical activity
would in the long term contribute to increased fat mass.
The fact that CON and FDR subjects had similar AT
glucose uptake after bed rest does to some extent reject
our a priori hypothesis that FDR subjects are more sensi-
tive to the unhealthy effects of physical inactivity than
CON subjects. However, it is worth noting that the abnor-
malities of whole-body and AT metabolism seen in FDR
subjects in their “native” normal activity state are compa-
rable to the metabolic abnormalities induced by 10 days of
bed rest in healthy CON subjects without any family
history of type 2 diabetes. Shifting to a sedentary lifestyle
causes less need for energy supply, especially to skeletal
muscle, wherefore lipolysis is expected to decrease, which
we did ﬁnd in SCFAT of both groups.
Interestingly, SCAAT GLUT-4 mRNA expression was
markedly upregulated by insulin in both groups after bed
rest, thus indicating that physical inactivity increases the
capacity of AT to respond to insulin stimulation and
supporting the ﬁnding of increased AT glucose uptake
after bed rest. Chronic hyperinsulinemia in rats induces
insulin resistance in skeletal muscle but a hyper-response
to insulin in AT, which is associated with an increase in AT
GLUT-4 mRNA and protein (30). Our study seems to
conﬁrm that hyperinsulinemia per se can produce diver-
gent effects in AT and skeletal muscle.
In the present study, increased plasma insulin (300
pmol/l) during the hyperinsulinemic euglycemic clamp did
not stimulate AT glucose uptake, lactate release, or blood
ﬂow. In support of our ﬁndings, previous studies have
revealed that even “supraphysiological” insulin concentra-
tions (1,600 pmol/l) barely stimulate glucose uptake in
AT (17,25) and that physiological concentrations of insulin
do not stimulate ATBF (17,25).
A multiple comparisons procedure was applied in the
present study, which introduces a risk of type I errors
wherefore caution is needed in the interpretation of the
results revealing variance heterogeneity. Furthermore,
noninherited factors, e.g., dietary habits and habitual
physical activity level, might differ between FDR and CON
subjects, which potentially could explain some of the
between-group differences before and in response to bed
rest.
In conclusion, FDR subjects show abnormalities in
subcutaneous AT metabolism prior to bed rest by display-
ing increased glucose uptake in SCAAT and decreased
SCAAT mRNA expression of lipases. Ten days of bed rest
decreases lipolysis and tends to increase glucose uptake in
SCFAT in both FDR and CON subjects, and SCAAT
glucose uptake is increased by bed rest in CON subjects to
the same level as in FDR subjects. Thus, with respect to
AT metabolism, FDR subjects are not more sensitive than
CON subjects to the unhealthy effects of physical inactiv-
ity, but the abnormalities of whole-body and AT metabo-
lism seen in FDR subjects prior to bed rest are comparable
with the metabolic abnormalities induced by 10 days of
bed rest in healthy CON subjects without any family
history of type 2 diabetes.
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